• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Practical Issues in the Management of Overt Hepatic Encephalopathy.显性肝性脑病管理中的实际问题
Gastroenterol Hepatol (N Y). 2017 Nov;13(11):659-665.
2
Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.原发性护理中肝硬化的并发症:肝性脑病的识别与管理。
Am J Med Sci. 2018 Sep;356(3):296-303. doi: 10.1016/j.amjms.2018.06.008. Epub 2018 Jun 19.
3
Understanding the impact of neurologic complications in patients with cirrhosis.了解肝硬化患者神经并发症的影响。
SAGE Open Med. 2019 Feb 28;7:2050312119832090. doi: 10.1177/2050312119832090. eCollection 2019.
4
Definition and nomenclature of hepatic encephalopathy.肝性脑病的定义与命名
J Clin Exp Hepatol. 2015 Mar;5(Suppl 1):S37-41. doi: 10.1016/j.jceh.2014.10.001. Epub 2014 Nov 28.
5
[Guidelines on the management of hepatic encephalopathy in cirrhosis].[肝硬化肝性脑病管理指南]
Zhonghua Nei Ke Za Zhi. 2018 Oct 1;57(10):705-718. doi: 10.3760/cma.j.issn.0578-1426.2018.10.004.
6
Diagnosis and management of hepatic encephalopathy.肝性脑病的诊断与管理
Br J Nurs. 2018 Feb 7;27(Sup3):S7-S13. doi: 10.12968/bjon.2018.27.Sup3.S7.
7
Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy.显性和隐性肝性脑病的当代认识与管理
Gastroenterol Hepatol (N Y). 2016 Feb;12(2):91-100.
8
Update on management of patients with overt hepatic encephalopathy.显性肝性脑病患者管理的最新进展。
Hosp Pract (1995). 2013 Aug;41(3):48-59. doi: 10.3810/hp.2013.08.1068.
9
Factors contributing to the development of overt encephalopathy in liver cirrhosis patients.导致肝硬化患者发生显性肝性脑病的因素。
Metab Brain Dis. 2016 Oct;31(5):1151-6. doi: 10.1007/s11011-016-9862-6. Epub 2016 Jun 29.
10
A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.肝硬化中显性肝性脑病诱因的新视角
Dig Dis Sci. 2017 Aug;62(8):2166-2173. doi: 10.1007/s10620-017-4630-y. Epub 2017 May 30.

引用本文的文献

1
Feasibility, Efficacy, and Safety of Percutaneous Muscle Biopsies in Patients With Chronic Liver Disease.慢性肝病患者经皮肌肉活检的可行性、有效性和安全性
Front Physiol. 2022 Feb 15;12:817152. doi: 10.3389/fphys.2021.817152. eCollection 2021.
2
Differentiation of hepatic encephalopathy from delirium tremens: A case series and review.肝性脑病与震颤谵妄的鉴别:病例系列及综述
Ind Psychiatry J. 2021 Oct;30(Suppl 1):S214-S220. doi: 10.4103/0972-6748.328865. Epub 2021 Oct 22.
3
Hepatic Encephalopathy: Diagnosis and Management.肝性脑病:诊断与管理
J Transl Int Med. 2020 Dec 31;8(4):210-219. doi: 10.2478/jtim-2020-0034. eCollection 2020 Dec.
4
Clinical management of type C hepatic encephalopathy.C 型肝性脑病的临床管理。
United European Gastroenterol J. 2020 Jun;8(5):536-543. doi: 10.1177/2050640620909675. Epub 2020 Feb 26.
5
Management of Hepatic Encephalopathy Not Responsive to First-Line Treatments.对一线治疗无反应的肝性脑病的管理
Curr Treat Options Gastroenterol. 2018 Jun;16(2):253-259. doi: 10.1007/s11938-018-0183-1.

本文引用的文献

1
A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.肝硬化中显性肝性脑病诱因的新视角
Dig Dis Sci. 2017 Aug;62(8):2166-2173. doi: 10.1007/s10620-017-4630-y. Epub 2017 May 30.
2
Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.终末期肝病中的电解质和酸碱平衡紊乱:一种生理病理学方法
Dig Dis Sci. 2017 Aug;62(8):1855-1871. doi: 10.1007/s10620-017-4597-8. Epub 2017 May 13.
3
Hepatic Encephalopathy.肝性脑病
N Engl J Med. 2016 Oct 27;375(17):1660-1670. doi: 10.1056/NEJMra1600561.
4
Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.糖尿病与肝硬化患者的临床失代偿事件相关。
Dig Dis Sci. 2016 Nov;61(11):3335-3345. doi: 10.1007/s10620-016-4261-8. Epub 2016 Aug 1.
5
Nutritional Status and its Impact on Clinical Outcomes for Patients Admitted to Hospital with Cirrhosis.肝硬化住院患者的营养状况及其对临床结局的影响。
J Med Assoc Thai. 2016 Feb;99 Suppl 2:S47-55.
6
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.不可吸收双糖与安慰剂/无干预措施对比,以及乳果糖与乳糖醇对比,用于肝硬化患者肝性脑病的预防和治疗
Cochrane Database Syst Rev. 2016 Apr 18;4:CD003044. doi: 10.1002/14651858.CD003044.pub3.
7
The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis.皇家自由医院营养优先排序工具是肝硬化患者肝功能恶化和生存的独立预测指标。
Dig Dis Sci. 2016 Jun;61(6):1735-43. doi: 10.1007/s10620-015-4015-z. Epub 2016 Jan 2.
8
Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited.肝硬化肝性脑病的发病机制:协同作用概念的再探讨
Metab Brain Dis. 2016 Dec;31(6):1211-1215. doi: 10.1007/s11011-015-9746-1. Epub 2015 Nov 2.
9
Recurrence of Subdural Haematoma in a Population-Based Cohort - Risks and Predictive Factors.基于人群队列的硬膜下血肿复发——风险及预测因素
PLoS One. 2015 Oct 14;10(10):e0140450. doi: 10.1371/journal.pone.0140450. eCollection 2015.
10
What is new about diet in hepatic encephalopathy.肝性脑病饮食方面有哪些新进展?
Metab Brain Dis. 2016 Dec;31(6):1289-1294. doi: 10.1007/s11011-015-9734-5. Epub 2015 Sep 29.

显性肝性脑病管理中的实际问题

Practical Issues in the Management of Overt Hepatic Encephalopathy.

作者信息

Pantham Ganesh, Mullen Kevin D

机构信息

Dr Pantham is a clinical instructor of medicine at Case Western University in Cleveland, Ohio, and a hospitalist in the Department of Medicine at the University Hospitals Cleveland Medical Center in Cleveland, Ohio. Dr Mullen is the section chief of digestive diseases and a professor of medicine at the West Virginia University School of Medicine in Morgantown, West Virginia.

出版信息

Gastroenterol Hepatol (N Y). 2017 Nov;13(11):659-665.

PMID:29230145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5717881/
Abstract

Hepatic encephalopathy (HE) is a condition that encompasses a range of neuropsychiatric abnormalities in patients with significant liver disease. Overt HE occurs in approximately 30% to 45% of patients with cirrhosis. This article discusses practical issues in the management of patients with overt HE and cirrhosis, including a recently developed 4-pronged approach that consists of identifying and correcting precipitating factors, recognizing and treating concomitant medical conditions, commencing empiric treatment, and caring for the unconscious patient. Following recovery from overt HE, a plan of action should be developed to prevent readmissions.

摘要

肝性脑病(HE)是一种在患有严重肝脏疾病的患者中出现一系列神经精神异常的病症。显性肝性脑病约发生于30%至45%的肝硬化患者中。本文讨论显性肝性脑病和肝硬化患者管理中的实际问题,包括最近制定的一种四管齐下的方法,该方法包括识别和纠正诱发因素、识别和治疗合并的内科疾病、开始经验性治疗以及护理昏迷患者。显性肝性脑病恢复后,应制定行动计划以防止再次入院。